Eli Lilly warns of dangerous impurities in knockoff weight-loss drugs.
Compounded versions of tirzepatide react with vitamin B12 to form an unknown substance.
This untested impurity could pose serious health risks with unknown long-term effects.
The FDA has warned about compounded drugs, and Lilly is urging a nationwide recall.
The risky market thrives due to high demand, shortages, and high costs of branded drugs.
The race for weight-loss solutions has taken another dangerous turn as pharmaceutical giant Eli Lilly issues a public warning about potentially hazardous knockoff versions of its blockbuster drugs. The company revealed that compounded versions of tirzepatide, the active ingredient in diabetes drug Mounjaro and weight-loss treatment Zepbound, are creating a dangerous and unknown impurity when mixed with a common additive: vitamin B12. This discovery throws a harsh light on the shadowy market of compounded copycats, revealing serious risks for consumers desperate for these in-demand medications.
Read Full Article: https://www.naturalnews.com/2026-03-13-impurity-in-knockoff-zepbound-forces-safety-warning.html
